Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Exercise | 2024-02-29 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 29,243 | $0 | 90,270 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 11,793 | $2.62 | 90,270 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:19 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 119,320 | $0 | 119,320 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-01 4:56 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 18,717 | $0 | 54,283 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-01 4:56 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 5,330 | $2.17 | 54,283 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 5:06 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 119,450 | $0 | 119,450 (Direct) | View |
| 2022-02-28 Exercise | 2022-02-28 7:18 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 11,300 | $0 | 27,763 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-02-28 7:18 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 3,337 | $2.85 | 27,763 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:02 pm | N/A 2032-02-10 | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 79,630 | $0 | 79,630 (Direct) | View |
Ownership | 2021-09-27 4:06 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 0 | $0 | 58,884 (Direct) | View |